{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:59:15Z","timestamp":1777669155067,"version":"3.51.4"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Institute of Health","award":["1R01HL154744"],"award-info":[{"award-number":["1R01HL154744"]}]},{"name":"National Institute of Health","award":["1R01HL129185-01"],"award-info":[{"award-number":["1R01HL129185-01"]}]},{"name":"National Institute of Health","award":["1R01HL129157"],"award-info":[{"award-number":["1R01HL129157"]}]},{"name":"National Institute of Health","award":["1R01HL127015"],"award-info":[{"award-number":["1R01HL127015"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["15EIA22710040"],"award-info":[{"award-number":["15EIA22710040"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Cardiovascular magnetic resonance (CMR) with late-gadolinium enhancement (LGE) is increasingly being used in hypertrophic cardiomyopathy (HCM) for diagnosis, risk stratification, and monitoring. However, recent data demonstrating brain gadolinium deposits have raised safety concerns. We developed and validated a machine-learning (ML) method that incorporates features extracted from cine to identify HCM patients without fibrosis in whom gadolinium can be avoided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>An XGBoost ML model was developed using regional wall thickness and thickening, and radiomic features of myocardial signal intensity, texture, size, and shape from cine. A CMR dataset containing 1099 HCM patients collected using 1.5T CMR scanners from different vendors and centres was used for model development (n=882) and validation (n=217). Among the 2613 radiomic features, we identified 7 features that provided best discrimination between +LGE and \u2212LGE using 10-fold stratified cross-validation in the development cohort. Subsequently, an XGBoost model was developed using these radiomic features, regional wall thickness and thickening. In the independent validation cohort, the ML model yielded an area under the curve of 0.83 (95% CI: 0.77\u20130.89), sensitivity of 91%, specificity of 62%, F1-score of 77%, true negatives rate (TNR) of 34%, and negative predictive value (NPV) of 89%. Optimization for sensitivity provided sensitivity of 96%, F2-score of 83%, TNR of 19% and NPV of 91%; false negatives halved from 4% to 2%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>An ML model incorporating novel radiomic markers of myocardium from cine can rule-out myocardial fibrosis in one-third of HCM patients referred for CMR reducing unnecessary gadolinium administration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjci\/jeab056","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T20:13:09Z","timestamp":1616184789000},"page":"532-542","source":"Crossref","is-referenced-by-count":34,"title":["Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy"],"prefix":"10.1093","volume":"23","author":[{"given":"Jennifer","family":"Mancio","sequence":"first","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"}]},{"given":"Farhad","family":"Pashakhanloo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"}]},{"given":"Hossam","family":"El-Rewaidy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"},{"name":"Department of Computer Science, Technical University of Munich, Arcisstra\u00dfe 21, 80333 Munich, Germany"}]},{"given":"Jihye","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"},{"name":"Department of Computer Science, Technical University of Munich, Arcisstra\u00dfe 21, 80333 Munich, Germany"}]},{"given":"Gargi","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"}]},{"given":"Ibolya","family":"Csecs","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"}]},{"given":"Long","family":"Ngo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"},{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA"}]},{"given":"Ethan","family":"Rowin","sequence":"additional","affiliation":[{"name":"HCM Institute, Division of Cardiology, Tufts Medical Centre, 860 Washington St Building, 6th Floor, Boston, MA 02111, USA"}]},{"given":"Warren","family":"Manning","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"},{"name":"Department of Radiology, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"}]},{"given":"Martin","family":"Maron","sequence":"additional","affiliation":[{"name":"HCM Institute, Division of Cardiology, Tufts Medical Centre, 860 Washington St Building, 6th Floor, Boston, MA 02111, USA"}]},{"given":"Reza","family":"Nezafat","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA"}]}],"member":"286","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"2022052310162252000_jeab056-B1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022052310162252000_jeab056-B2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2022052310162252000_jeab056-B3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jchf.2018.02.010","article-title":"Hypertrophic cardiomyopathy: clinical update","volume":"6","author":"Geske","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2022052310162252000_jeab056-B4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022052310162252000_jeab056-B5","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2022052310162252000_jeab056-B6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ackd.2017.03.004","article-title":"Gadolinium retention and toxicity-an update","volume":"24","author":"Ramalho","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"2022052310162252000_jeab056-B7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/RLI.0000000000000374","article-title":"Critical questions regarding gadolinium deposition in the brain and body after injections of the gadolinium-based contrast agents, safety, and clinical recommendations in consideration of the EMA's pharmacovigilance and risk assessment committee recommendation for suspension of the marketing authorizations for 4 linear agents","volume":"52","author":"Runge","year":"2017","journal-title":"Invest Radiol"},{"key":"2022052310162252000_jeab056-B8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00330-012-2597-9","article-title":"Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines","volume":"23","author":"Thomsen","year":"2013","journal-title":"Eur Radiol"},{"key":"2022052310162252000_jeab056-B9","doi-asserted-by":"crossref","first-page":"e009894","DOI":"10.1161\/CIRCIMAGING.119.009894","article-title":"Multicenter study on the diagnostic performance of native-T1 cardiac magnetic resonance of chronic myocardial infarctions at 3T","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022052310162252000_jeab056-B10","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/s41598-018-25693-1","article-title":"Detection of recent myocardial infarction using native T1 mapping in a swine model: a validation study","volume":"8","author":"Cui","year":"2018","journal-title":"Sci Rep"},{"key":"2022052310162252000_jeab056-B11","doi-asserted-by":"crossref","first-page":"e005986","DOI":"10.1161\/CIRCIMAGING.116.005986","article-title":"CMR native T1 mapping allows differentiation of reversible versus irreversible myocardial damage in ST-segment-elevation myocardial infarction: an OxAMI Study (Oxford Acute Myocardial Infarction)","volume":"10","author":"Liu","year":"2017","journal-title":"Cir Cardiovasc Imaging"},{"key":"2022052310162252000_jeab056-B12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcmg.2017.04.006","article-title":"Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy","volume":"11","author":"Nakamori","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022052310162252000_jeab056-B13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jmri.25885","article-title":"Native T(1) reference values for nonischemic cardiomyopathies and populations with increased cardiovascular risk: a systematic review and meta-analysis","volume":"47","author":"van den Boomen","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"2022052310162252000_jeab056-B14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1148\/radiology.180.3.1871277","article-title":"Magnetization transfer contrast in MR imaging of the heart","volume":"180","author":"Balaban","year":"1991","journal-title":"Radiology"},{"key":"2022052310162252000_jeab056-B15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12968-017-0411-1","article-title":"Optimized CEST cardiovascular magnetic resonance for assessment of metabolic activity in the heart","volume":"19","author":"Zhou","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022052310162252000_jeab056-B16","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1002\/mrm.27636","article-title":"Non-contrast myocardial infarct scar assessment using a hybrid native T1 and magnetization transfer imaging sequence at 1.5T","volume":"81","author":"Duan","year":"2019","journal-title":"Magn Reson Med"},{"key":"2022052310162252000_jeab056-B17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2011.10.137","article-title":"Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy","volume":"166","author":"Schuster","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022052310162252000_jeab056-B18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ehjci\/jex235","article-title":"Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial","volume":"19","author":"Foley","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022052310162252000_jeab056-B19","doi-asserted-by":"crossref","first-page":"e016797","DOI":"10.1161\/JAHA.120.016797","article-title":"Association between left ventricular mechanical deformation and myocardial fibrosis in nonischemic cardiomyopathy","volume":"9","author":"Csecs","year":"2020","journal-title":"JAHA"},{"key":"2022052310162252000_jeab056-B20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ehjci\/jeaa028","article-title":"Cardiac magnetic resonance radiomics: basic principles and clinical perspectives","volume":"21","author":"Raisi-Estabragh","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022052310162252000_jeab056-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2020.00001","article-title":"Image-based cardiac diagnosis with machine learning: a review","volume":"7","author":"Martin-Isla","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2022052310162252000_jeab056-B22","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"2022052310162252000_jeab056-B23","doi-asserted-by":"crossref","first-page":"591368","DOI":"10.3389\/fcvm.2020.591368","article-title":"Radiomics signatures of cardiovascular risk factors in cardiac MRI: results from the UK Biobank","volume":"7","author":"Cetin","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2022052310162252000_jeab056-B24","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","article-title":"Radiomics: the process and the challenges","volume":"30","author":"Kumar","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"2022052310162252000_jeab056-B25","doi-asserted-by":"crossref","first-page":"120950","DOI":"10.1016\/j.conbuildmat.2020.120950","article-title":"Efficient machine learning models for prediction of concrete strengths","volume":"266","author":"Nguyen","year":"2021","journal-title":"Constr Build Mater"},{"key":"2022052310162252000_jeab056-B26","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1088\/0031-9155\/61\/13\/R150","article-title":"Applications and limitations of radiomics","volume":"61","author":"Yip","year":"2016","journal-title":"Phys Med Biol"},{"key":"2022052310162252000_jeab056-B27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1148\/radiol.2017170213","article-title":"Subacute and chronic left ventricular myocardial scar: accuracy of texture analysis on nonenhanced cine MR images","volume":"286","author":"Baessler","year":"2018","journal-title":"Radiology"},{"key":"2022052310162252000_jeab056-B28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejrad.2018.03.013","article-title":"Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-preliminary results","volume":"102","author":"Bae\u00dfler","year":"2018","journal-title":"Eur J Radiol"},{"key":"2022052310162252000_jeab056-B29","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2022052310162252000_jeab056-B30","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"2022052310162252000_jeab056-B31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2152\/jmi.66.35","article-title":"Standardization of imaging features for radiomics analysis","volume":"66","author":"Haga","year":"2019","journal-title":"J Med Invest"},{"key":"2022052310162252000_jeab056-B32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol Aspects Med"},{"key":"2022052310162252000_jeab056-B33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N Engl J Med"},{"key":"2022052310162252000_jeab056-B34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10741-018-9718-8","article-title":"Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis","volume":"23","author":"Zhuang","year":"2018","journal-title":"Heart Fail Rev"},{"key":"2022052310162252000_jeab056-B35","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.jcmg.2018.11.024","article-title":"Radiomic analysis of myocardial native T(1) imaging discriminates between hypertensive heart disease and hypertrophic cardiomyopathy","volume":"12","author":"Neisius","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022052310162252000_jeab056-B36","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jmri.27048","article-title":"Texture signatures of native myocardial T(1) as novel imaging markers for identification of hypertrophic cardiomyopathy patients without scar","volume":"52","author":"Neisius","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"2022052310162252000_jeab056-B37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ahj.2011.03.022","article-title":"Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy","volume":"161","author":"Conte","year":"2011","journal-title":"Am Heart J"},{"key":"2022052310162252000_jeab056-B38","doi-asserted-by":"crossref","first-page":"1980636","DOI":"10.1155\/2016\/1980636","article-title":"Echocardiography as a screening test for myocardial scarring in children with hypertrophic cardiomyopathy","volume":"2016","author":"Compton","year":"2016","journal-title":"Int J Pediatr"},{"key":"2022052310162252000_jeab056-B39","doi-asserted-by":"crossref","first-page":"102726","DOI":"10.1016\/j.ebiom.2020.102726","article-title":"A low-cost texture-based pipeline for predicting myocardial tissue remodeling and fibrosis using cardiac ultrasound","volume":"54","author":"Kagiyama","year":"2020","journal-title":"EBioMedicine"},{"key":"2022052310162252000_jeab056-B40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1751-7133.2008.tb00002.x","article-title":"Screening for asymptomatic left ventricular dysfunction using B-type natriuretic peptide","volume":"14","author":"McDonagh","year":"2008","journal-title":"Congestive Heart Fail"},{"key":"2022052310162252000_jeab056-B41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cmpb.2017.02.003","article-title":"Location of mammograms ROI's and reduction of false-positive","volume":"143","author":"Salazar-Licea","year":"2017","journal-title":"Comput Methods Programs Biomed"},{"key":"2022052310162252000_jeab056-B42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/RLI.0000000000000530","article-title":"Robustness and reproducibility of radiomics in magnetic resonance imaging: a phantom study","volume":"54","author":"Bae\u00dfler","year":"2019","journal-title":"Invest Radiol"},{"key":"2022052310162252000_jeab056-B43","doi-asserted-by":"crossref","first-page":"586236","DOI":"10.3389\/fcvm.2020.586236","article-title":"Repeatability of cardiac magnetic resonance radiomics: a multi-centre multi-vendor test-retest study","volume":"7","author":"Raisi-Estabragh","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2022052310162252000_jeab056-B44","doi-asserted-by":"crossref","first-page":"e190216","DOI":"10.1148\/ryct.2020190216","article-title":"Reproducibility of segmentation-based myocardial radiomic features with cardiac MRI","volume":"2","author":"Jang","year":"2020","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2022052310162252000_jeab056-B45","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.27581","article-title":"Sensitivity of myocardial radiomic features to imaging parameters in cardiac MR imaging","author":"Jang","year":"2021","journal-title":"J Mag Res Imaging"},{"key":"2022052310162252000_jeab056-B46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/23808993.2019.1585805","article-title":"Deep learning and radiomics in precision medicine","volume":"4","author":"Parekh","year":"2019","journal-title":"Expert Rev Precis Med Drug Dev"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/23\/4\/532\/43794584\/jeab056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/23\/4\/532\/43794584\/jeab056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T10:17:11Z","timestamp":1653301031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/23\/4\/532\/6199608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,3,29]]},"published-print":{"date-parts":[[2022,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeab056","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,3,29]]}}}